Roga

Roga operates at the intersection of consumer health wearables, mental-health support, and neuroscience-led wellness. Its core product is described as a discreet wearable that delivers gentle pulsed electrical stimulation behind the ears, paired with a mobile app offering guided audio and video sessions. This combination differentiates its stated approach from app-only mindfulness services and general-purpose wearable trackers: the device is intended to provide a physical intervention while the app supplies complementary stress-management content. Roga also describes a workplace mental-health platform, extending its potential use beyond individual consumers. No reliable external competitor names are identified in the company’s similarity information; the entries there duplicate Roga rather than identify peers. It would therefore be misleading to assign named competitors or claim a category ranking. Its competitive position is best understood as a differentiated product concept in a crowded wellness market, with validation and adoption evidence still limited.

Roga’s funding history indicates an early-stage trajectory: a $100,000 grant on Feb 12, 2022, a $500,000 pre-seed round on Mar 14, 2022, and a $1.2 million pre-seed round on Feb 28, 2024. The total is $1.8 million, with Exceptional Ventures leading the latest listed round and Ontario Brain Institute leading the grant. Product activity has centered on the Roga Device and Roga Life App, with replacement electrode pads and a corporate mental-health platform described as complementary offerings. A wearable launch reported in November 2022 and an India launch announcement in January 2024 suggest efforts to bring the device to market and reach new users. Overall, the record suggests gradual development from early funding toward product commercialization, but provides little evidence on revenue, user growth, clinical validation, or the pace of expansion.